682805-00-1 Usage
Uses
Used in Pharmaceutical Research:
2-Fluoro-4-methoxycinnamic acid is used as a building block for the synthesis of biologically active molecules, contributing to the development of new drugs and therapies.
Used in Organic Synthesis:
2-Fluoro-4-methoxycinnamic acid is used as an intermediate in the synthesis of various organic compounds, facilitating the creation of a wide range of chemical products.
Used in Medicine:
2-Fluoro-4-methoxycinnamic acid is used as a potential therapeutic agent for its anti-inflammatory and antioxidant properties, offering benefits in the treatment of various diseases and conditions.
Used in Agriculture:
2-Fluoro-4-methoxycinnamic acid is used in the development of agrochemicals, potentially contributing to more effective and targeted pest control solutions.
Used in Material Science:
2-Fluoro-4-methoxycinnamic acid is used in the research and development of new materials, with potential applications in various industries due to its unique properties.
Check Digit Verification of cas no
The CAS Registry Mumber 682805-00-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,8,2,8,0 and 5 respectively; the second part has 2 digits, 0 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 682805-00:
(8*6)+(7*8)+(6*2)+(5*8)+(4*0)+(3*5)+(2*0)+(1*0)=171
171 % 10 = 1
So 682805-00-1 is a valid CAS Registry Number.
InChI:InChI=1/C10H9FO3/c1-14-8-4-2-7(9(11)6-8)3-5-10(12)13/h2-6H,1H3,(H,12,13)/p-1/b5-3+
682805-00-1Relevant academic research and scientific papers
New coumarin/sulfocoumarin linked phenylacrylamides as selective transmembrane carbonic anhydrase inhibitors: Synthesis and in-vitro biological evaluation
Angeli, Andrea,Arifuddin, Mohammed,Singh, Priti,Supuran, Claudiu T.,Swain, Baijayantimala
, (2020/07/03)
Two novel series of phenylacrylamide linked coumarins and sulfocoumarins (6a-p, 8a-i, and 14a-g) were synthesized and evaluated against four physiologically relevant human carbonic anhydrases (hCAs, EC 4.2.1.1), isoforms hCA I, hCA II, hCA IX and hCA XII for their inhibitory action. All new compounds when screened for carbonic anhydrase inhibitory activity have shown selective inhibition towards the tumor associated isoforms hCA IX and XII over CA I and II, with inhibition constants in the submicromolar to low nanomolar range. Compound 6b and 14g exhibited significant inhibition with low nanomolar potency against hCA IX, whereas 6k was effective against hCA XII. Compounds 6b, 14g and 6k may be considered as lead molecules for future development of cancer therapeutics based on a novel mechanism of action.
